| Financial Year |
March 31 2023 |
| Monetary Funds |
696,605,602.04 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
24,427,083.36 |
| Accounts Receivable |
9,555,809.93 |
| Advances to Suppliers |
23,927,391.58 |
| Other Receivables |
160,126,586.58 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
28,220,841.36 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
480,223,841.49 |
| Total Current Assets |
1,441,642,429.27 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
9,769,378.05 |
| Investment Properties |
4,922,337.88 |
| Fixed Assetes |
53,139,250.29 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
-- |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
-- |
| Deferred Income Tax Assets |
8,140,576.22 |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
191,927,777.77 |
| Total Assets |
1,633,570,207.04 |
| Short-Term Loans |
66,729,990.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
46,125,201.98 |
| Accounts Payable |
1,152,989.66 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
11,235,272.66 |
| Taxes Payable |
6,492,524.87 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
89,946,034.85 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
-- |
| Other Current Liabilities |
106,392,929.36 |
| Sub-Total of Current Liabilities |
406,005,023.45 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
587,374.91 |
| Deferred Income Tax Liabilities |
2,337,505.63 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
28,709,799.32 |
| Total Liabilities |
434,714,822.77 |
| Paid-In Capital(Or Share Stock) |
252,720,000.00 |
| Capital Surplus |
326,122,334.75 |
| Surplus Reserve |
57,073,425.69 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
299,992,370.24 |
| Minority Stockholder's Interest |
265,044,097.95 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
933,811,286.32 |
| Owner's Equity（Stockholder's Equity） |
1,198,855,384.27 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,633,570,207.04 |
